Takeda Pharmaceutical Company Limited (TAK) Oveporexton (TAK-861) Investor Call On Phase 3 Narcolepsy Type 1 Data Presented At World Sleep 2025 (Transcript)
Source: SeekingAlpha
2025-09-08 16:51:43 ET
Takeda Pharmaceutical Company Limited (TAK) Oveporexton (TAK-861) Investor Call on Phase 3 Narcolepsy Type 1 Data Presented at World Sleep 2025...
Read the full article on Seeking Alpha
For further details see:
Takeda Pharmaceutical Company Limited (TAK) Oveporexton (TAK-861) Investor Call On Phase 3 Narcolepsy Type 1 Data Presented At World Sleep 2025 (Transcript)
Takeda Pharmaceutical Co Ltd
NASDAQ: TKPHF
TKPHF Trading
0.0% G/L:
$37.83 Last:
113 Volume:
$37.83 Open:
TKPHF Latest News
TKPHF Stock Data
$55,801,616,447
1,559,387,460
N/A
724
N/A
Pharmaceuticals
Healthcare
JP
Chuo-ku
